Valuation: Biogen Inc.

Market Cap 34.37B 30.56B 28.32B 25.77B 48.62B 3,262B 49.4B 340B 133B 1,702B 129B 126B 5,427B P/E 2026 *
37.8x
P/E 2027 * 20.7x
Enterprise Value 39.32B 34.95B 32.4B 29.47B 55.62B 3,732B 56.51B 389B 153B 1,947B 148B 144B 6,208B EV / Sales 2026 *
3.77x
EV / Sales 2027 * 3.46x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week+3.07%
Current month+3.00%
1 month+7.70%
3 months+11.36%
6 months+32.17%
Current year+32.20%
1 week 226.71
Extreme 226.71
240.99
1 month 214.59
Extreme 214.59
240.99
Current year 160.36
Extreme 160.3645
240.99
1 year 138
Extreme 138
240.99
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 27/10/2024
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/10/26 Exercice

Controller/Auditor

62 0.0000%
01/09/26 Free

General Counsel

7,405 0.0050%
04/08/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%+3.07%+63.54%-13.17% 34.37B
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.28%+3.56%+38.00%+54.17% 397.53B
Weighted average by Cap. +0.12%+3.83%+39.39%+70.70%

Financials

2026 *2027 *
Net sales 10.44B 9.28B 8.6B 7.83B 14.77B 991B 15B 103B 40.53B 517B 39.18B 38.34B 1,648B 10.64B 9.46B 8.76B 7.97B 15.05B 1,010B 15.29B 105B 41.31B 527B 39.92B 39.07B 1,680B
Net income 983M 873M 809M 736M 1.39B 93.25B 1.41B 9.73B 3.81B 48.66B 3.69B 3.61B 155B 1.86B 1.65B 1.53B 1.39B 2.63B 176B 2.67B 18.38B 7.21B 91.92B 6.97B 6.82B 293B
Net Debt 4.94B 4.4B 4.07B 3.71B 6.99B 469B 7.11B 48.97B 19.2B 245B 18.56B 18.16B 781B 2.4B 2.13B 1.97B 1.8B 3.39B 227B 3.44B 23.74B 9.31B 119B 9B 8.8B 378B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
16/10/26 US$232.65 -1.15% 1,462,717
15/10/26 US$235.35 +1.08% 1,572,453
14/10/26 US$232.83 +1.72% 1,947,327
13/10/26 US$228.90 -0.22% 1,049,196
12/10/26 US$229.41 +1.64% 1,462,073
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
232.65USD
Average target price
243.98USD
Spread / Average Target
+4.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock